Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Failure to Follow Up on Pharmacy Recommendations and Medication Management

Indianapolis, Indiana Survey Completed on 04-25-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency occurred when the facility failed to ensure timely follow-up on pharmacy recommendations for a resident reviewed for unnecessary medications. The resident, who had a history of stroke and was cognitively intact, had a pharmacy recommendation to discontinue fenofibrate and obtain a fasting lipid panel four weeks after discontinuation. Although the physician agreed with the recommendation and ordered the lab, the facility was unable to provide evidence that the lipid panel was completed as ordered. Additionally, the same resident was prescribed prophylactic antibiotics for urinary tract infection prevention. The pharmacy recommended discontinuing both nitrofurantoin and trimethoprim or documenting the intended duration of therapy. The physician referred the case to urology, but the resident did not attend the follow-up appointment, and there was no documentation of urology consultation regarding the continued use of antibiotics. The Director of Nursing was unable to explain the rationale for the resident being on two prophylactic antibiotics simultaneously.

An unhandled error has occurred. Reload 🗙